Browse by Journal or Publication Title

G

Garvican, L and Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X (2004) A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes. Diabetic Medicine, 21 (10). pp. 1066-1074. doi:10.1111/j.1464-5491.2004.01300.x

H

Harding, S, Greenwood, R, Aldington, S, Gibson, J, Owens, D, Taylor, R, Kohner, E, Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X and Leese, G (2003) Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabetic Medicine, 20 (12). pp. 965-971. doi:10.1111/j.1464-5491.2003.01077.x

M

Moreton, R B, Stratton, I M, Chave, S J, Lipinski, H and Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X (2017) Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabetic Medicine, 34 (7). pp. 993-999. doi:10.1111/dme.13350

O

Oke, J L, Stratton, I M, Aldington, S J, Stevens, R J and Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X (2016) The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme. Diabetic Medicine, 33 (7). pp. 896-903. doi:10.1111/dme.13053

S

Sallam, A, Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Stratton, I M, Jones, V, Martin, C N, Brelen, M and Johnston, R L (2011) Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy. Diabetic Medicine, 28 (6). pp. 741-746. doi:10.1111/j.1464-5491.2011.03273.x

Scanlon, P. H. ORCID: https://orcid.org/0000-0001-8513-710X, Norridge, C. F. E., Prentis, D., Holman, N., Rankin, P. and Valabhji, J. (2025) Effect of the COVID ‐19 pandemic on diabetic retinopathy and referral levels in the English National Health Service Diabetic Eye Screening Programme. Diabetic Medicine, 42 (5). e15518. doi:10.1111/dme.15518

Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X (2012) The preferences of people with diabetes for diabetic retinopathy screening. Diabetic Medicine, 29 (7). pp. 836-837. doi:10.1111/j.1464-5491.2012.03630.x

Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Aldington, S. J. and Stratton, I. M. (2013) Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy. Diabetic Medicine, 31 (4). pp. 439-442. doi:10.1111/dme.12313

Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Loftus, J, Starita, C. and Stratton, I M (2015) The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial. Diabetic Medicine, 32 (1). pp. 97-101. doi:10.1111/dme.12593

Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Malhotra, R, Thomas, G, Foy, C, Kirkpatrick, J N, Lewis-Barned, N, Harney, B and Aldington, S J (2003) The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabetic Medicine, 20 (6). pp. 467-474.

Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Martin, M. L., Bailey, C., Johnson, E., Hykin, P. and Keightley, S. (2006) Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy. Diabetic Medicine, 23 (1). pp. 60-66. doi:10.1111/j.1464-5491.2005.01736.x

Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Stratton, I M, Leese, G P, Bachmann, M O, Land, M, Jones, C and Ferguson, B (2016) Screening attendance, age group and diabetic retinopathy level at first screen. Diabetic Medicine, 33 (7). pp. 904-911. doi:10.1111/dme.12957

Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X, Stratton, I. M., Bachmann, M. O., Jones, C. and Leese, G. P. (2016) Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age. Diabetic Medicine, 33 (12). pp. 1655-1658. doi:10.1111/dme.13263

Smith, J.J., Wright, D.M., Scanlon, Peter H. ORCID: https://orcid.org/0000-0001-8513-710X and Lois, N. (2020) Risk Factors Associated with Progression to Referable Retinopathy: A Type 2 Diabetes Mellitus Cohort Study in the Republic of Ireland. Diabetic Medicine, 37 (6). pp. 1000-1007. doi:10.1111/dme.14278

W

West, S D, Groves, D C, Lipinski, H J, Nicoll, D J, Mason, R H, Scanlon, Peter H ORCID: https://orcid.org/0000-0001-8513-710X and Stradling, J R (2010) The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabetic Medicine, 27 (4). pp. 423-430. doi:10.1111/j.1464-5491.2010.02962.x